BackTetraLogic Pharmaceuticals Overview

TetraLogic Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for TLOG.

Quarterly EBIT

-$14.66M
↓ 40.53% YoY

As of Sep 30, 2016

Annual EBIT (TTM)

-$49.19M
↓ 24.99% YoY

Trailing 12 months ending Sep 30, 2016

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin